BREAKING
KVH Industries Inc (KVHI) Reports Q4 Earnings 4 hours ago Nio Inc (NIO) Beats Q4 EPS Estimates by a Wide Margin 5 hours ago Ultralife Corp (ULBI) Reports a net loss for Q4 FY25 5 hours ago Protara Therapeutics, Inc. (TARA) Reports Narrower Loss for Q4 5 hours ago Apyx Medical Corporation (APYX) Reports a Net Loss for Q4 FY25 5 hours ago Esperion Therapeutics, Inc (ESPR) Misses Q4 EPS Estimates 5 hours ago Inspired Entertainment, Inc (INSE) Misses Q4 EPS Estimates 6 hours ago DNTH Stock Jumps 21.5% Despite Wider-Than-Expected Q4 Loss as Pipeline Prospects Fuel Rally 6 hours ago SuRo Capital Corp (SSSS) Reports Wider Loss Q4 EPS Estimates by 10.0% 7 hours ago Tenax Therapeutics Inc (TENX) Reports Q4 Earnings 7 hours ago KVH Industries Inc (KVHI) Reports Q4 Earnings 4 hours ago Nio Inc (NIO) Beats Q4 EPS Estimates by a Wide Margin 5 hours ago Ultralife Corp (ULBI) Reports a net loss for Q4 FY25 5 hours ago Protara Therapeutics, Inc. (TARA) Reports Narrower Loss for Q4 5 hours ago Apyx Medical Corporation (APYX) Reports a Net Loss for Q4 FY25 5 hours ago Esperion Therapeutics, Inc (ESPR) Misses Q4 EPS Estimates 5 hours ago Inspired Entertainment, Inc (INSE) Misses Q4 EPS Estimates 6 hours ago DNTH Stock Jumps 21.5% Despite Wider-Than-Expected Q4 Loss as Pipeline Prospects Fuel Rally 6 hours ago SuRo Capital Corp (SSSS) Reports Wider Loss Q4 EPS Estimates by 10.0% 7 hours ago Tenax Therapeutics Inc (TENX) Reports Q4 Earnings 7 hours ago
ADVERTISEMENT
Analysis

Eagle Point Credit Company Reports Stable Quarterly Revenue with Continued Monthly Distributions

$ECC February 17, 2026 2 min read
Alphastreet Vertex Pharma Q4 2025 Earnings Results
NYSE
$ECC · Earnings

Eagle Point Credit Company, Inc.

Current Status Overview

Eagle Point Credit Company, Inc. is a publicly traded closed-end investment company focused primarily on equity and junior debt tranches of collateralized loan obligations. As of February 17, 2026, the company continues to operate within its structured credit investment strategy. The company maintains monthly distribution payments and actively manages a diversified portfolio of CLO investments. Estimated net asset value for the most recent quarter reflects ongoing portfolio activity amid broader credit market volatility.

Share Price Performance

The latest trading price is approximately $4.47 per share. The stock has experienced downward movement in recent sessions and is trading near its 52-week low range. Volatility has been observed over the past several weeks amid broader market fluctuations. The share price remains below prior year levels.

Revenue Performance

Rolling revenue performance based on reported quarterly results indicates stability in recent periods. Revenue for the latest three-month period totaled approximately $52 million. Six-month cumulative revenue reached approximately $104 million. Nine-month cumulative revenue totaled approximately $156 million. Quarterly revenue contributions have remained consistent across the measured periods.

Market Analysis

The company operates within the closed-end fund sector specializing in structured credit investments. Performance is influenced by credit market conditions, interest rate trends, and underlying loan performance within CLO structures. High distribution yields remain a defining feature of the company’s market positioning. Competition includes other publicly traded closed-end funds and alternative credit investment vehicles.

Analyst Commentary

No recent comprehensive analyst commentary or consensus rating updates are publicly available at this time.

ADVERTISEMENT

Mergers & Acquisitions

None reported.

Outlook

Forward guidance has not materially changed. Future performance will depend on credit market stability, interest rate developments, and portfolio income generation. The outlook remains subject to prevailing market conditions.

ADVERTISEMENT
Tags: #ECC